BI
Biovica International AB (publ)
BIOVIC-B.ST · STO
0.42 kr -0.47% (-0.00 kr)
1M -23.73%
Market Cap 117.4M kr
P/E Ratio -
Div. Yield -
ROE 81.76%
Piotroski F-Score Weak
3/9Valuation
50 /100
Fair P/S 8.77x
P/B 1.36x
P/E N/A
Growth
78 /100
Growing Rev. growth 58.13%
Book val. growth 14.60%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 362.77%
FCF margin 472.95%
Net margin 522.13%
Quality
2 /100
Poor ROIC 77.07%
Asset turnover 0.12x
ROE 81.76%
Debt
69 /100
Low Debt/Equity 0.05x
Int. coverage -176.12x
Current ratio 4.30x
Stability
44 /100
Moderate Beta 1.16x
Profitable years 0
Rev. volatility 49.06%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre BIOVIC-B.ST
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Theis Kipling
Employees
25
Headquarters
Uppsala
Evenimente viitoare
10 SEPT.
Earnings
Upcoming earnings report